Navigation Links
Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
Date:1/23/2013

LONDON, Jan. 23, 2013 /PRNewswire/ -- In a shaky economic climate, where fund raising has become tight and there are decreasing opportunities to exit the market, venture capital (VC) firms have become extremely cautious in choosing their investments. This has led to the trend of low value deals. However, segments like healthcare equipment have got sizeable injections of new funding, with such positive trends set to continue.

New analysis from Frost & Sullivan (http://www.financialservices.frost.com), Analysis of Venture Capital Investment Trends in the European Healthcare Industry, notes that drug delivering technologies and those focusing on product life cycle management of existing drugs are expected to attract VC investments.

"Patent expiration and lengthy approval times have increased the costs of drug development," says Frost & Sullivan Financial Analyst Dr. E. Saneesh. "This, coupled with a slowing economy, has made VC investors reluctant to invest more in new drug development. Instead, they have focused on enhanced drug delivery technologies and product life cycle management technologies."

While investments in pharmaceuticals and biotechnology decreased from 2010 to March 2012, healthcare equipment displayed sustained investments.

"Healthcare equipment is attracting VC investments because the innovations in this segment reduce the healthcare delivery costs, making the delivery easier," explains Dr. Saneesh. "Shorter product development cycles result in faster returns and, moreover, product approvals here are not as complex as those required for drugs."

However, regulatory variations across countries present a barrier for companies wanting to access VC funding. This has also affected fund raising efforts by VC firms.

Another concern is that the high costs and extended approval times related to drug development ha
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
3. Omeros Announces Proposed Public Offering of Common Stock
4. Ampio Pharmaceuticals Announces Proposed Public Offering
5. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
6. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
7. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
8. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
9. Jason Pharmaceuticals, Inc. Reaches Proposed Consent Agreement with FTC
10. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
11. Isis Pharmaceuticals Announces Proposed Offering of $175 Million of Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the sale to Galderma of all rights to Restylane, ... Valeant for $1.4 billion in cash, pursuant to the ... its acquisition of Galderma. "We are ... a company that is firmly committed to the aesthetic ...
(Date:7/10/2014)... , July 10, 2014   LabStyle Innovations ... Solution, today announced the appointment of Professor ... of its Board of Directors. Prof. ... business experience to LabStyle as an entrepreneur, venture ... and corporate governance expert. He currently serves on ...
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  $2,650,000 ... sales of $2,202,000 for the prior year period, an increase ... shown growth over the preceding quarter,s sales, continuing a trend ... Markets that experienced sales increases over the prior year were ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... Correlated With Clinical Response, CHICAGO, May ... today highlighted the potential of its,investigational MAGE-A3 ... studies evaluating highly targeted immunotherapy,as a treatment ... cancer,(NSCLC). These data were presented at the ...
... in preventing ... Contrast-Induced Nephropathy, FRANKLIN, Mass., May 30 ... on innovative cardiac and vascular medical,device-based technologies, announced today that ... Milan, Italy has,approved the planned randomized clinical trial to evaluate ...
Cached Medicine Technology:New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 2New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 3New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 5New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 6New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 7PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 2PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 3PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 4PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM) 5
(Date:7/13/2014)... Ticket Down is a reliable ... For the fifth straight year (and second under the ... at American stadiums this summer. The tournament features eight club ... eight teams are split into two groups of four and ... teams will compete to become champion. One team that has ...
(Date:7/13/2014)... for diagnosing type-1 diabetes could improve patient care ... according to the device,s inventors at the Stanford ... paper to be published online July 13 in ... to detect type-1 diabetes outside hospital settings. The ... of diabetes mellitus, which are both characterized by ...
(Date:7/13/2014)... The North American water storage systems market is estimated to ... 2018, at a CAGR of 21.0%, from 2013 to 2018. ... pace in North America. The U.S. is experiencing high growth ... storage and collection, and the increased spending on modernization and ... healthy rate in Canada, and is rising at a rapid ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
(Date:7/13/2014)... Serena Gordon HealthDay ... A new type of sensor for people with diabetes ... using saliva instead of blood, researchers report. Scientists at ... tested it using artificial saliva. It uses light, metal and ... sugar. "Everybody knows that diabetics have to prick their ...
Breaking Medicine News(10 mins):Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 3Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 2Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 3Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 4Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
... do not provide coverage to international ... ... one of the,industry,s most experienced travel health insurance providers, alerts,parents and ... abroad for spring break vacations. Most health insurance,programs do not provide ...
... SALT LAKE CITY, March 10 ZARS ... agreement providing Galderma Pharma S.A. the,exclusive promotion ... the,United States and Canada for Pliaglis(TM) (lidocaine ... provides effective and safe local,anesthesia in patients ...
... from mice in a dramatic 2004 study has shown ... The researcher who conducted both studies says the disappointing ... treat childrens cancers, at least until there is a ... Ph.D., a developmental biologist at The Childrens Hospital of ...
... X-ray crystallography, researchers at the University of Pittsburgh School ... Ph.D., have become the first to decipher the three-dimensional ... role in glycerol metabolism a discovery that could ... potential host of other diseases. Their findings are reported ...
... a study presented today at the Society of Gynecologic Oncologys ... on the path toward better management of ovarian cancer. Researchers ... combination of proteins, or biomarkers in the blood called HE4 ... womans risk for the disease dubbed the silent killer. Currently ...
... of Philadelphia is pleased to name Mary Beth ... The appointment follows an,extensive national search., (Photo: ... Children,s Hospital, Esposito-Herr served as the Vice,President of ... Medical,Center, where she also held a joint appointment ...
Cached Medicine News:Health News:Seven Corners Alerts Spring Breakers that They Need Travel Insurance to Vacation Abroad 2Health News:Seven Corners Alerts Spring Breakers that They Need Travel Insurance to Vacation Abroad 3Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 3Health News:Potential brain cancer drug for children may damage bones 2Health News:Potential brain cancer drug for children may damage bones 3Health News:University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein 2Health News:University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein 3Health News:University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein 4Health News:Malignant tumor or benign cyst? 2Health News:Malignant tumor or benign cyst? 3Health News:The Children's Hospital of Philadelphia Appoints New Chief Nursing Officer 2
... The MEL 80 is a top quality ... the correction of vision defects even safer, ... of this ultramodern work platform are oriented ... and the rapid recovery of vision. Key ...
Code-Ready defibrillator a defibrillator designed to provide clinicians with comprehensive support for resuscitation....
... be mounted at the patient's bedside, on ... The design retains many of the proven ... the pump drive motor circuits, flow estimator, ... system. Retaining these subsystems maintains compatibility ...
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Medicine Products: